Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Harbour BioMed
Biotech
Harbour BioMed docks with BMS in antibody research deal
Bristol Myers Squibb is the latest Big Pharma to tie up a biotech pact as we reach the year’s end, tapping Harbour for a multiyear research deal.
Ben Adams
Dec 17, 2025 8:55am
Otsuka's $670M pact to point Harbour's TCE to autoimmune disease
Jun 23, 2025 6:29am
AstraZeneca details $2.5B investment in China's political center
Mar 21, 2025 8:35am
Harbour launches obesity biotech on mission to preserve muscle
Mar 12, 2025 8:15am
Harbour spinoff pens $395M deal for preclinical Crenessity rival
Feb 26, 2025 5:14am
Windward generates $200M with Novo Holdings, OrbiMed in tow
Jan 10, 2025 10:02am
